(1)
Gordon, K.; Foley, P.; Rich, P.; Duffin, K.; Pinter, A.; Griffiths, C.; Wang, M.; Vanvoorden, V.; Staelens, F.; Ciaravino, V.; Merola, J. Bimekizumab Versus Ustekinumab in Plaque Psoriasis: Lasting Efficacy Translates to Rapid and Sustained Improvements in Quality of Life in the BE VIVID Multicenter, Randomized, Double-Blinded Phase 3 Trial. J of Skin 2021, 5, s17.